Decreasing Cardiovascular Risk for Patients with Persistent Hypercholesterolemia–An Animated Whiteboard View

Released On
October 7, 2019

Expires On
October 7, 2020

Media Type
Internet

Completion Time
60 minutes

Specialty
Cardiology

Topic(s)
CVD

Scroll to the Bottom of this Information to Begin this Course

Jointly provided by Med Learning Group and Ultimate Medical Academy/CCM.

 

Supported by an educational grant from Sanofi US/Regeneron Pharmaceuticals.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 contact hour(s).

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This CME initiative is designed to meet the needs of lipidologists, cardiologists, endocrinologists, and other healthcare professionals involved in the management of patients at high risk for cardiovascular disease (CVD) due to hypercholesterolemia.

Program Overview

This enduring activity is focused on the management and care of patients with hypercholesterolemia who are at high risk for cardiovascular disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss how lowering LDL-C levels can reduce CVD risk in patients with persistently elevated cholesterol levels
  • Review clinical trial data on nonstatin LDL-C–lowering agents in patients with persistently elevated LDL-C levels and evidence regarding their positioning in treatment regimens
  • Describe best practices for identifying and managing patients with persistently elevated LDL-C levels and at high risk for CVD

Faculty

Christie M. Ballantyne, MD

Professor of Medicine, Molecular and Human Genetics
Chief of Cardiology and Cardiovascular Research
Director, The Maria and Alando J. Ballantyne, MD, Atherosclerosis Clinical Research Laboratory
Baylor College of Medicine
Houston, Texas

Physician Continuing Medical Education

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Purpose: This program would be beneficial for nurses involved in the management and care of patients with hypercholesterolemia who are at high risk for cardiovascular disease.

Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Christie Ballantyne, MD

  • Grant/Research Support: Abbott Diagnostic, Akcea, Amgen, Esperion, Novartis, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, NIH, ADA, AHA
  • Consultant Fees : Abbott Diagnostic, Akcea, Amarin, Amgen, Astra Zeneca, Boehringer Ingelheim, Denka Seiken, Esperion, Intercept, Janssen, Matinas BioPharma Inc, Merck, Novartis, Novo Nordisk, Regeneron, Roche Diagnostic, Sanofi-Synthelabo
  • Provisional Patent: “Biomarkers to Improve Prediction of Heart Failure Risk” (patent no. 61721475) filed by Baylor College of Medicine and Roche.

CME content review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.

Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.

Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.

Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.

Brianna Hanson, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. Understand the material, pass the intra-activity questions and complete an evaluation to receive credit. Passing grade is 70% and you are limited to 5 attempts. To receive CME credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.

You will receive your certificate for download immediately, you will also get an email reminder.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Content - Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Click to view: Whiteboard Toolkit

Click to view: Whiteboard Hypercholesterolemia Poster